Genotype 4 hepatitis C virus: Beware of
โ
Sepideh Akhavan; Christophe Ronsin; Syria Laperche; Vincent Thibault
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 632 KB
Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.